BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...
BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...
LAKE FOREST, Calif., November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for ...
STAAR Surgical (NASDAQ:STAA) rose 6.5% amid some takeover speculation. The maker of implantable lenses is said to have been ...
Hosted on MSN6mon
STAAR Surgical pares earlier gain amid takeover speculation, turns negative (update)Update 3:35pm: Updates shares, adds STAAR surgical response. "We are very pleased with our momentum in 2024 and will provide an update on our performance on our 2Q earnings call in early August ...
What is the current share price of STAAR Surgical Company (STAA)? STAAR Surgical Company's (STAA) current share price is $27.72. This constitutes a price movement of 3.90% when compared to the share ...
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback